×
About 580 results

ALLMedicine™ Adult-onset Still's Disease Center

Research & Reviews  228 results

Expression signature of inflammation-associated long non-coding RNAs in adult-onset Sti...
https://www.ncbi.nlm.nih.gov/pubmed/34524081
Clinical and Experimental Rheumatology; Yang CA, Chen PK et. al.

Sep 16th, 2021 - Adult-onset Still's disease (AOSD) is a rare and complex inflammatory disease with unclear immunopathogenesis. This study aims to investigate the expression signature of inflammation-associated long non-coding RNAs (lncRNAs) in AOSD and to evaluat...

Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
https://doi.org/10.1007/s00296-021-04978-1 10.1016/j.autrev.2014.01.058 10.1016/j.berh.2008.08.006 10.1038/s41584-018-0081-x 10.1002/art.1780290316 10.1002/art.1780280207 10.1186/s13075-017-1406-x 10.1080/14397595.2018.1514999 10.1136/annrheumdis-2019-215239 10.3390/ijms22147760 10.3389/fimmu.2021.674343 10.1016/j.gene.2015.01.023 10.1038/s41419-018-0570-5 10.1016/j.taap.2019.114702 10.1002/(sici)1097-0215(20000401)86:1<47::aid-ijc7>3.0.co;2-r 10.1136/ard.2008.094664 10.1016/j.intimp.2019.05.024 10.1080/08916934.2020.1755965 10.3899/jrheum.100247 10.1093/rheumatology/kew300 10.1093/rheumatology/keab023 10.1089/bio.2015.0104 10.1111/j.1399-0039.2008.01134.x 10.1038/sj.gene.6363922 10.1002/1529-0131(200107)44:7<1716::Aid-Art298>3.0.Co;2-I 10.1136/ard.2003.013680 10.1186/s13075-020-02200-4 10.3390/ijms19072012 10.1016/j.febslet.2004.08.036 10.1038/nrrheum.2017.205 10.1016/j.ccell.2017.10.003 10.1084/jem.172.6.1535 10.1038/nm0603-669 10.1210/edrv.18.1.0287 10.1074/jbc.271.2.736 10.1111/j.0022-202X.2004.22735.x 10.1016/j.intimp.2005.04.002 10.1016/s0736-5748(99)00048-9 10.1038/nri3787 10.1016/j.chom.2016.05.016 10.1038/nrrheum.2009.237 10.1016/j.coi.2020.10.014 10.1084/jem.20180861
Rheumatology International; Chen X, Hu QY et. al.

Sep 10th, 2021 - In view of the possible involvement of vascular endothelial growth factor-C (VEGF-C) in pathogenesis of adult-onset Still's disease (AOSD) based on our previous genome-wide association study (GWAS) results, the primary objective of this study, the...

Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A s...
https://doi.org/10.1016/j.semarthrit.2021.08.007
Seminars in Arthritis and Rheumatism; Cota-Arce JM, Cota J et. al.

Sep 9th, 2021 - Adult-onset Still's disease (AOSD) is a rare inflammatory disease, typically characterized by spiking fever, skin rash, and arthralgia or arthritis. Its conventional treatment includes NSAIDs and corticosteroids, and DMARDs as second-line therapy....

Synovial fluid cell count of 84 930/mm3 in adult-onset Still's disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386203
BMJ Case Reports; Winberg C, Ladak K

Aug 26th, 2021 - In traditional teaching, synovial fluid cell counts over 50 000/mm3 are in keeping with septic or crystalline arthritis. We report a patient with adult-onset Still's disease (AOSD) and associated inflammatory arthritis whose synovial fluid cell co...

Adult-onset Still's disease following pneumococcal vaccination.
https://doi.org/10.1684/ejd.2021.4102
European Journal of Dermatology : EJD; Sato T, Takeo N et. al.

Aug 25th, 2021 - Adult-onset Still's disease following pneumococcal vaccination.|2021|Sato T,Takeo N,Matsuda-Hirose H,Abe K,Nishida H,|

see more →

News  4 results

FDA Approves Canakinumab (Ilaris), First Drug for Adult-Onset Still's Disease
https://www.medscape.com/viewarticle/932625

Jun 19th, 2020 - The Food and Drug Administration has expanded the indications for canakinumab (Ilaris) to include all patients with active Still's disease older than 2 years, adding adult-onset Still's disease (AOSD) to a previous approval for juvenile-onset Stil...

IL-6 for Adult Still's: A New Option?
https://www.medpagetoday.com/rheumatology/generalrheumatology/75699

Oct 14th, 2018 - Action Points Some clinical benefits were seen among patients with adult-onset Still's disease treated with tocilizumab (Actemra) in a small clinical trial, but the study's primary endpoint was not met. During the double-blind part of the trial, t...

Steroids and DMARDs Needed in Adult-Onset Still's
https://www.medpagetoday.com/rheumatology/arthritis/21574

Aug 7th, 2010 - Action Points Explain to interested patients that in this study of patients with adult-onset Still's disease (aka systemic juvenile idiopathic arthritis), treatment with NSAIDs alone was usually not effective whereas steroids usually were. Note th...

Anakinra Promising in Pediatric Inflammation
https://www.mdedge.com/rheumatology/article/44666/pediatrics/anakinra-promising-pediatric-inflammation
Kate Johnson

Response to anakinra treatment was rapid and sustained in most patients with adult-onset Still's disease and in a “significant proportion” of patients with systemic-onset juvenile idiopathic arthritis, according to a study. The results suggest the.

see more →